DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20210807

Study of determinants of cardiovascular morbidity among diabetes patients

Subha Sankha Kundu, Kunal Kanti Majumdar, Dipankar Mukherjee, Rajib Sikder, Rituraj Dey, Gautam Kumar Joardar

Abstract


Background: With the change in lifestyle and behavior among individuals, the prevalence of T2DM is on rise. Many modifiable and non-modifiable risk factors are attributable for the cardiovascular morbidity among the diabetics which is the leading cause of mortality and morbidity among them, also increasing their burden of expenditure. The purpose of this study was to determine the prevailing factors responsible and its associate co morbidities among the Type 2 Diabetes Mellitus patients.

Methods: It was a descriptive, observational and cross sectional study conducted for 30 days. 226 patients who visited the diabetes OPD of the Medical College were interviewed using a pre-designed questionnaire, anthropometric measurements, systemic and general examinations were performed. The data was analysed using suitable statistical analysis.

Results: Out of 226 patients, 47.8% were suffering from cardiovascular morbidity, majority being heart failure (57.4%). Most of them were contributed 46.3% and 38.9% by age group 50-59 years (46.3%) and 60-69 years (38.9%), 55.6% were smokers and 64.4% were overweight. 70.4% complained of stress in their daily life while 48.1% were unaware of their heart conditions until checkup. 18.5% of the patients also suffered from retinopathy and 37.03% from diabetic foot ulcer. 64% of them had hypertension and 67.2% had sedentary life style.

Conclusions: Many modifiable and non-modifiable risk factors were found associated with cardiovascular morbidity among the type 2 diabetes mellitus patients. So a proper awareness and life style modifications might be necessary to decrease cardiovascular morbidity among them.


Keywords


Atherosclerosis, Cardio vascular morbidity, Diabetes, Hypertension

Full Text:

PDF

References


Harris M, Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance. In: International Textbook of Diabetes Mellitus. Chichester: John Willey and Sons Ltd; 1997:9-23.

Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676-85.

Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-7.

Dokken BB. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 2008;21(3):160-5.

Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia. 1985;28:615-40.

Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939-42.

IDF Diabetes Atlas Ninth edition 2019. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed on 22 February 2020.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83.

Mohan V, Venkatraman JV, Pradeepa R. Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol. 2010;4(1):158-70.

Alwakeel JS, Sulimani R, Al-Asaad H, Al-Harbi A, Tarif N, Al-Suwaida A, et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med. 2008;28:260-6.

Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Rutten GE, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55:2154-62.

Alaboud AF, Tourkmani AM, Alharbi TJ, Alobikan AH, Abdelhay O, Al Batal SM, et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J. 2016;37:1408-11.

Alonso-Moran E, Orueta JF, Fraile Esteban JI, Arteagoitia Axpe JM, Marques Gonzalez ML, Toro Polanco N, et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health. 1059;2014:14.

Carrasco-Sánchez FJ, Gomez-Huelgas R, Formiga F, Conde-Martel A, Trullàs JC, Bettencourt P, et al. Associ ation between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: fndings from the RICA registry. Diabetes Res Clin Pract. 2014;104:410-9.

Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfeld S, Geiss L, et al. Trends in death rates among US adults with and without diabetes between 1997 and 2006. Diabetes Care. 2012;35:1252-7.

Lin PJ, Cohen JT, Kent WA, Neumann PJ. Patterns of comorbidity clusters among adults with diabetes. Value Health. 2013;16:A155-6.

Song S, Hardisty C. Early onset type 2 diabetes mellitus: a harbinger for complications in later years- clinical observation from a secondary care cohort. QJM. 2009;102:799-806.

Yang HK, Kang B, Lee SH, Yoon KH, Hwang BH, Chang K, et al. Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes. J Diab Complicat. 2015;29:776-82.

Bhatti GK, Bhadada SK, Vijayvergiya R, Mastana SS, Bhatti JS. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and cardiovascular disease study- NID CVD-2. J Diab Complicat. 2016;30:72-8.

Malik MO, Govan L, Petrie JR, Ghouri N, Leese G, Fischbacher C, et al. Ethnicity and risk of cardiovas cular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia. 2015;58:716-25.

Mansour AA, Ajeel NA. Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah. World J Diabetes. 2013;4:82.

Menghua Z. GW25-e1447 clinical signifcance of multislice coronary CT angiography in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2014;64:C227.

Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 2008;31:1582-4.

Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year followup of participants in the Framingham Heart study. Circulation. 1983;67:968-77.

Masmiquel L, Leiter L, Vidal J, Bain S, Petrie J, Franek E, et al. Gaal Lv: LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016;15:29.

Huang Y, Li J, Zhu X, Sun J, Ji L, Hu D, et al. Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY. Acta Diabetol. 2017;54:569-79

Simmons RK, Grifn SJ, Lauritzen T, Sandbæk A. Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2017;60:2192-9.

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.

Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Hafner S, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the treating to new targets (TNT) study. Diabetes Care. 2006;29:1220-6.

Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S, et al. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16:95.